Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration
Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration
复制标题
DOI:
10.1007/s10549-011-1844-0
复制
发表时间:
2012-06-01
影响因子:
3.8
通讯作者:
Feng, Zuo-Hua
中科院分区:
文献类型:
--
作者:
Liao, Sheng-Jun;Zhou, Yuan-Hong;Feng, Zuo-Hua
Triggering of Toll-like receptor 4 (TLR4) on tumor cells has been found to promote tumor progression by promoting tumor cell proliferation and survival. So far, however, the effect of TLR4 signaling on tumor metastasis has not been well elucidated. Here, we report that triggering of TLR4 on metastatic breast cancer cells could reciprocally regulate the expression of alpha v beta 3 and the expressions of TPM1 and maspin, and promote alpha v beta 3-mediated adhesion and invasive migration of the cells. In metastatic breast cancer cells, TLR4 signaling increased the expression of integrin alpha v beta 3 by activating NF-kappa B, resulting in the increased adhesion capacity of tumor cells to the ligand for alpha v beta 3, and the increased polymerization of actin and production of MMP-9 in tumor cells in response to ECM. HoxD3 was required for the up-regulation of alpha v and beta 3 expressions by NF-kappa B. Moreover, TLR4 signaling increased the expression of miR-21 in breast cancer cells by activating NF-kappa B. Accordingly, the expressions of TPM1 and maspin were decreased at protein level, whereas the transcription activity of these genes was not influenced. Consistent with the promoting effect on alpha v beta 3-mediated adhesion and invasive migration, TLR4 signaling promoted the arrest of metastatic breast cancer cells in circulation and following invasion. The effect of TLR4 signaling could be abrogated by inhibiting NF-kappa B. These findings suggest that metastatic breast cancer cells could acquire higher metastatic potential due to triggering of TLR4 and activation of NF-kappa B in the cells, and that both TLR4 and NF-kappa B could be therapeutic targets for preventing metastasis of breast cancer cells.